Pesticide residues on everyday food may be shaping neurodevelopmental outcomes before birth — a finding with broad implications for dietary guidance during pregnancy. While organophosphate (OP) pesticides have long been recognized as neurotoxicants, the specific relationship between prenatal OP burden and autism spectrum traits has remained scientifically contested. This large pooled analysis helps resolve some of that uncertainty.
Drawing on harmonized data from 20 cohort sites within the NIH's Environmental influences on Child Health Outcomes (ECHO) program, researchers measured prenatal OP exposure using two urinary biomarkers: TCPy, a metabolite of chlorpyrifos, and the summed dialkyl phosphate (ΣDAP) metabolites representing broader OP contact. Autism-related traits in children aged 2 to 19 were quantified via the Social Responsiveness Scale (SRS), a validated continuous measure sensitive to subclinical autistic features. Multivariable regression models — including linear, quantile, and logistic approaches — tested associations while controlling for sociodemographic and behavioral confounders. Crucially, the team also examined whether maternal diet quality modified the exposure-outcome relationship and stratified results by child sex.
This study's scale and methodological rigor place it several rungs above prior single-cohort work, which has produced inconsistent results partly due to small samples and heterogeneous exposure assessment. The ECHO consortium's harmonized design substantially reduces that noise. The sex-stratified analysis is particularly important: male-biased vulnerability in ASD is well-established epidemiologically, and if OP-associated neurotoxicity follows the same pattern, it would support shared biological pathways — possibly involving androgen-OP interactions or differential placental metabolism. The maternal diet modifier is equally noteworthy, because dietary OP intake is the primary exposure route for most U.S. pregnant women, meaning diet quality functions simultaneously as a protective factor and an exposure vector. A key limitation is that urinary biomarkers reflect a snapshot of exposure rather than cumulative gestational burden, and reverse causation cannot be fully excluded in observational designs. Still, for a question with genuine public health stakes — OP residues appear in roughly three-quarters of U.S. urine samples — this constitutes meaningful confirmatory evidence warranting attention from clinicians and nutrition researchers alike.